-+ 0.00%
-+ 0.00%
-+ 0.00%

Aurora Cannabis urges shareholders to take no action on Curaleaf hostile bid

PUBT·08/24/2026 11:05:31
Listen to the news
Aurora Cannabis urges shareholders to take no action on Curaleaf hostile bid
  • Curaleaf launched an unsolicited take-over bid for Aurora Cannabis, targeting its EU-GMP manufacturing network and global medical cannabis footprint.
  • Aurora set up a special committee of independent directors to review the proposal with financial and legal advisers.
  • The offer is open for at least 105 days from the start of the bid.
  • Aurora cited fiscal Q1 2027 international net revenue growth of 17% year over year, with Germany a key driver.
  • The group recently expanded in the UK through the acquisitions of Internode Pharma and HAP Pharma.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Aurora Cannabis Inc. published the original content used to generate this news brief via PR Newswire (Ref. ID: 202608240705PR_NEWS_USPR_____TO31883) on August 24, 2026, and is solely responsible for the information contained therein.